Correspondingly, SKP2 degradation has been reported to suppress aerobic glycolysis and inhibit colorectal cancer growth, underscoring its role in promoting glycolytic metabolism and tumor progression (47). This evidence concerns the gene SKP2 and colorectal cancer.